- Home
- /
- Treatment
- /
- Page 29
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Recombinant human interleukin-12 | Acute Radiation Syndrome Acute radiation syndrome | Coté Orphan Consulting UK Limited | August 29, 2016 | |
Recombinant humanised monoclonal antibody against human complement component C5a | Graft Versus Host Disease | Alexion Europe SAS | August 29, 2016 | |
Sodium benzoate | Ornithine translocase deficiency | Lucane Pharma SA | August 29, 2016 | |
6′-(R)-methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)-paromamine sulfate | Hurler syndrome | Coté Orphan Consulting UK Limited | August 29, 2016 | |
Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene | Duchenne muscular dystrophy | Pfizer Limited | August 29, 2016 | |
Synthetic double-stranded small interfering RNA (siRNA) oligonucleotide targeting delta-aminoevulinic acid synthase 1 | Variegate porphyria | Alnylam Pharmaceuticals;300 Third Street;Cambridge, Massachusetts, 02142 | August 29, 2016 | |
Fimaporfin | Bile duct cancer | PCI Biotech AS | August 29, 2016 | |
Masitinib mesilate | Amyotrophic lateral sclerosis | AB Science | August 29, 2016 | |
S-ethylisothiourea diethylphosphate | Symptomatic intradialytic hypotension, including symptomatic hypotension in the immediate post-dialytic period | TrioxBio, Inc.;P. O. Box 1000;Wilmington, Delaware, 19801 | August 29, 2016 | |
Valproic Acid | McArdle’s disease | Vall d'Hebron Institute of Research | August 29, 2016 | |
9,10-dimethoxy-5,6-dihydro-[1,3] dioxolo[4,5-g]isoquinolino[3,2-alpha]isoquinolin-7-ium(R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyhexadecahydro-1H-cyclopenta[alpha] | Primary sclerosing cholangitis | HighTide Biopharma Pty. Ltd.;1 Melissa Street;Mount Waverley | August 29, 2016 | |
Methotrexate | Alkaptonuria | aimAKU (Associazione Italiana Malati di Alcaptonuria) | August 29, 2016 | |
Recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1) | Primary sclerosing cholangitis | Acorda Therapeutics, Inc.;420 Saw Mill River Road;Ardsley, New York, 10502 | August 25, 2016 | |
Ublituximab | Neuromyelitis optica | TG Therapeutics, Inc.;3 Columbus Circle, 15th Floor;New York, New York, 10019 | August 25, 2016 | |
Phosphoinositide-3-kinase delta inhibitor | Chronic lymphocytic leukemia | TG Therapeutics, Inc.;3 Columbus Circle, 15th Floor;New York, New York, 10019 | August 23, 2016 | |
(1,3)-�-D-glucan synthesis inhibitor | Invasive Aspergillus infections | SCYNEXIS, Inc.;101 Hudson Street, Suite 3610;Jersey City, New Jersey, 07302 | August 22, 2016 | |
(1,3)-ß-D-glucan synthesis inhibitor | Invasive Aspergillus infections | SCYNEXIS, Inc.;101 Hudson Street, Suite 3610;Jersey City, New Jersey, 07302 | August 22, 2016 | |
Ambrisentan/tadalafil fixed combination | Pulmonary Arterial Hypertension | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 | August 22, 2016 | |
Stabilized sulforaphane | Subarachnoid hemorrhage | Evgen Pharma PLC;146 Brownlow Hill;Liverpool | August 22, 2016 | |
Disufenton sodium | Glioblastoma | Oblato, Inc.;116 Village Boulevard;Princeton, New Jersey, 08540 | August 22, 2016 | |
Recombinant human interleukin-12 | Acute Radiation Syndrome Acute radiation syndrome | Neumedicines, Inc.;133 Altadena Drive, Suite 133;Pasadena, California, 91107 | August 22, 2016 | |
Live E. coli Nissle bacterium modified to assimilate ammonia | Urea cycle disorders | Synlogic, Inc.;200 Sidney Street, #320;Cambridge, Massachusetts, 02139 | August 22, 2016 | |
Etrolizumab | Ulcerative colitis | Genentech, Inc.;1 Dna Way;South San Francisco, California, 94080 | August 22, 2016 | |
Rituximab and recombinant human hyaluronidase | Chronic lymphocytic leukemia | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | August 22, 2016 | |
Rituximab and recombinant human hyaluronidase | Follicular lymphoma | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | August 22, 2016 |